When Sadness Has a Medical Name
Sadness is a feeling. It arises in response to real circumstances — loss, rejection, grief — and it fades as those circumstances change or as time passes. That is not a failure of the emotional system; it is the system working correctly, processing difficult experiences and moving through them.
Depression is not that process intensified or prolonged. It is a distinct medical condition characterized by persistent changes in mood, cognition, energy, sleep, appetite, and physical function — changes that operate independent of whether a person’s life circumstances actually warrant them (Mayo Clinic, 2023). A person with major depressive disorder (MDD) may feel profoundly hopeless on a day when nothing, by any external measure, is wrong. Or they may feel nothing at all — not sadness, not joy — which is often more disorienting than crying, and harder to explain to people who expect depression to look a certain way.
The clinical criteria for MDD require that a person experience persistent low mood or loss of interest in activities they previously cared about, present most of the day and nearly every day, for at least two weeks. But equally central to the diagnosis is anhedonia — a word clinicians use to describe the loss of pleasure in activities that once mattered, from relationships to work to things a person used to love. Alongside these core features, MDD typically involves fatigue that sleep does not repair, difficulty concentrating, slowed thinking, changes in appetite and weight, physical aches without a clear physical cause, and a pervasive sense of worthlessness or guilt that is disproportionate to any actual circumstances (Mayo Clinic, 2023).
These are not personality traits. They are not character failures. They are symptoms of a disorder that affects the brain, and understanding that distinction is one of the most important steps a person can take toward getting appropriate care.
What Depression Does to the Brain
One of the most significant and least-discussed features of depression is its effect on cognitive function. Research has documented that depression produces measurable impairment in working memory, attention, and the ability to process and recall information (PMC). This is not simply the consequence of being distracted by difficult emotions — it is a direct neurological effect of how depression alters brain chemistry over time.
This finding matters because many people with depression describe a symptom they rarely see acknowledged: the sense that their mind is moving through fog, that thoughts form slowly and incompletely, that they cannot hold information the way they used to. They may forget conversations, miss details at work, or struggle to complete tasks that once came easily. None of this reflects intelligence or effort. It reflects the fact that a depressive episode is doing something measurable to the brain, and that cognitive impairment is a documented feature of the disorder.
Understanding this also reframes what can feel like a paradox: many people with depression know, intellectually, that they should seek help, but find themselves unable to initiate the steps required to do it. Researching providers, making phone calls, and explaining a complex history all require precisely the cognitive capacities that depression erodes. At KetaMed, our clinical team — led by Michelle Ridgeway, a board-certified Psychiatric Mental Health Nurse Practitioner, and Dr. Mirza Umair Baig, a board-certified Emergency Medicine physician — understands that arriving at a consultation at all is often a significant act. We have designed our process accordingly: a free initial consultation, no rushed appointments, and a provider who listens before recommending anything.
The Relationship Between Depression and Anxiety
Depression rarely presents alone. Research confirms a strong bidirectional relationship between depression and anxiety disorders — each condition elevates the risk and severity of the other, and they co-occur frequently enough that treating one while ignoring the other often leaves meaningful suffering in place (American Journal of Psychiatry). For many people, the experience is not cleanly one or the other. It is the withdrawal and emotional flatness of depression alongside the restlessness, hypervigilance, and persistent worry of anxiety.
This matters clinically because someone whose depression is accompanied by significant anxiety may not respond fully to treatments designed for depression alone. At KetaMed, we approach every patient’s presentation as a whole — not as a single diagnosis to be addressed in isolation, but as a complete picture that deserves a treatment plan tailored to all of what the person is experiencing.
How We Approach Depression at KetaMed
We are physician-led and veteran-owned, and we have spent four years serving patients across the Delmarva Peninsula who have tried standard options and found them insufficient. We offer three treatment modalities for depression: IV ketamine therapy, IM (intramuscular) ketamine therapy, and ketamine troches — dissolvable oral lozenges used under clinical supervision.
Each approach works through the glutamate system, a neurological pathway distinct from the serotonin-targeted mechanisms of traditional antidepressants like SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors). For patients whose depression has not responded to those standard medications, this difference in mechanism may be clinically significant.
IV ketamine is our most comprehensive option. Sessions last 45 to 120 minutes in a calm, monitored clinical setting, and most mental health patients begin with a series of six treatments. IM ketamine offers a shorter session time — typically 30 to 60 minutes total — for patients who want a simpler process with similar therapeutic goals. Ketamine troches provide a more accessible entry point, starting at $100, and may serve as an initial option or as a maintenance pathway following IV or IM treatment. Pricing for IV and IM treatment varies based on individual treatment plans and is discussed during your consultation.
Results vary by individual. We do not operate from a fixed protocol and we do not make promises about outcomes. What we do commit to is that every treatment plan is built around your specific symptoms, history, and response over time — and adjusted as needed throughout.
When Cost and Stigma Get in the Way
Two things commonly prevent people from taking the next step toward care, and we think both deserve a direct answer.
The first is stigma. Depression is still widely mischaracterized as weakness, as excessive sensitivity, or as something a person could resolve through effort or attitude. The neurological evidence does not support this. But internalizing that characterization — or anticipating judgment from others — can make it genuinely difficult to reach out, even when someone knows something is wrong. We built KetaMed for people who have been dismissed, told to push through, or handed a prescription without a real conversation. You do not need to justify your experience before we take it seriously.
The second is cost. We do not accept insurance at this time. We have kept our pricing transparent and accessible — ketamine troches start at $100, and pricing for IV and IM treatments is discussed openly during your free consultation with no hidden fees and no pressure. If cost is a concern, we encourage you to contact us directly so we can walk through your options honestly.
Frequently Asked Questions
What is the clinical definition of depression? Major depressive disorder is defined as a persistent low mood or loss of interest in activities, present most of the day and nearly every day for at least two weeks, accompanied by additional symptoms including fatigue, cognitive impairment, and changes in sleep or appetite. The diagnosis requires that these symptoms cause significant distress or interfere with daily functioning, and that they are not explained by another medical condition or substance use. A licensed provider makes this determination based on a full clinical evaluation.
Why do some people with depression feel numb instead of sad? Emotional numbness — clinically referred to as anhedonia — is a common and diagnostically recognized feature of major depressive disorder. It describes a flattening of emotional experience in which neither sadness nor pleasure feels accessible. For many people, this is the most disabling aspect of depression because it removes the emotional signal that something is wrong, making the condition harder to name and harder for others to recognize.
Can depression affect memory and thinking? Yes. Cognitive impairment is a documented feature of depression, not a secondary complaint. People with MDD commonly experience difficulty with working memory, concentration, and processing speed. These effects are neurological in origin, not a reflection of intelligence or effort, and they often improve as depression is effectively treated.
Does anxiety make depression worse? Research shows a strong bidirectional relationship between anxiety and depression — each condition increases the likelihood and severity of the other. Many people with depression also experience significant anxiety, and treatment that addresses only one dimension often leaves the other unresolved. Discussing both aspects of your experience with your provider helps ensure the treatment plan accounts for the full picture.
Key Takeaways
- Major depressive disorder is a medical condition with measurable neurological features — it is not sadness that has lasted too long or intensified too much.
- Core symptoms include persistent low mood or emotional numbness, loss of pleasure in activities, cognitive impairment, and physical changes present for at least two weeks.
- Depression frequently co-occurs with anxiety, and effective care often needs to address both dimensions.
- Cognitive impairment is a documented feature of depression and may make initiating care more difficult — a free consultation at KetaMed is the first step, with no pressure and no prerequisites.
- Results vary by individual; personalized treatment planning matters because no single protocol is appropriate for everyone.
If the experience you have been living with does not fit neatly into the word “sadness” — if there is numbness, cognitive fog, or a flatness that no amount of pushing through has resolved — that is not a personal failing. That is clinical information. We invite you to schedule a free consultation with us at KetaMed in Salisbury, Maryland. You can reach us by phone at 877-247-2949 or by email at info@ketamedinfusions.com. We serve patients across the Delmarva Peninsula, by appointment, and we will give you a straight answer about what your options are.
References
- Mayo Clinic. (2023). Depression (major depressive disorder) — Symptoms and causes. https://www.mayoclinic.org/diseases-conditions/depression/symptoms-causes/syc-20356007
- PMC. Cognitive impairment in depression. https://pmc.ncbi.nlm.nih.gov/articles/PMC5835184/
- American Journal of Psychiatry. The comorbidity of major depression and anxiety disorders. https://psychiatryonline.org/doi/10.1176/appi.ajp.2020.20030305
Medical Disclaimer
The information in this blog is for educational purposes only and does not constitute medical advice. Ketamine therapy for depression should only be considered under the supervision of a licensed medical provider who is familiar with your full medical and psychiatric history. Individual results vary, and no specific outcomes are guaranteed. KetaMed Infusions does not diagnose or treat any condition without a thorough clinical evaluation. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline, or go to your nearest emergency room.